Article
New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas
6 Sept 2021
Abstract excerpt
Splenic marginal zone lymphoma (SMZL) is a small B-cell lymphoma, which has been recognized as a distinct pathological entity since the WHO 2008 classification. It classically presents an indolent evolution, but a third of patients progress rapidly and require aggressive treatments, such as immuno-chemotherapy or splenectomy, with all associated side effects. In recent years, advances in the comprehension of SMZL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
